← All trials
NCT05008393
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2021
- Primary completion
- Nov 30, 2021
- Completion date
- Dec 30, 2021
- First posted
- Aug 17, 2021
- Last posted
- Oct 1, 2021
- Enrollment
- 150
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hospital do CoracaoLead sponsor
- Hospital do CoracaoOverall official - principal investigator
- Hospital do CoracaoStudy director
- CoviceptCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.